General Information of Drug Off-Target (DOT) (ID: OTNMQGZS)

DOT Name TSC22 domain family protein 4 (TSC22D4)
Synonyms TSC22-related-inducible leucine zipper protein 2
Gene Name TSC22D4
Related Disease
Neoplasm ( )
Hyperglycemia ( )
Neoplasm of esophagus ( )
Type-1/2 diabetes ( )
UniProt ID
T22D4_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF01166
Sequence
MSGGKKKSSFQITSVTTDYEGPGSPGASDPPTPQPPTGPPPRLPNGEPSPDPGGKGTPRN
GSPPPGAPSSRFRVVKLPHGLGEPYRRGRWTCVDVYERDLEPHSFGGLLEGIRGASGGAG
GRSLDSRLELASLGLGAPTPPSGLSQGPTSWLRPPPTSPGPQARSFTGGLGQLVVPSKAK
AEKPPLSASSPQQRPPEPETGESAGTSRAATPLPSLRVEAEAGGSGARTPPLSRRKAVDM
RLRMELGAPEEMGQVPPLDSRPSSPALYFTHDASLVHKSPDPFGAVAAQKFSLAHSMLAI
SGHLDSDDDSGSGSLVGIDNKIEQAMDLVKSHLMFAVREEVEVLKEQIRELAERNAALEQ
ENGLLRALASPEQLAQLPSSGVPRLGPPAPNGPSV
Function
Binds DNA and acts as a transcriptional repressor. Involved in the regulation of systematic glucose homeostasis and insulin sensitivity, via transcriptional repression of downstream insulin signaling targets such as OBP2A/LCN13. Acts as a negative regulator of lipogenic gene expression in hepatocytes and thereby mediates the control of very low-density lipoprotein release. May play a role in neurite elongation and survival.
Tissue Specificity Expressed in the liver.

Molecular Interaction Atlas (MIA) of This DOT

4 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Neoplasm DISZKGEW Strong Altered Expression [1]
Hyperglycemia DIS0BZB5 Limited Biomarker [2]
Neoplasm of esophagus DISOLKAQ Limited Biomarker [3]
Type-1/2 diabetes DISIUHAP Limited Biomarker [2]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
4 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of TSC22 domain family protein 4 (TSC22D4). [4]
Arsenic DMTL2Y1 Approved Arsenic affects the methylation of TSC22 domain family protein 4 (TSC22D4). [8]
PMID28870136-Compound-52 DMFDERP Patented PMID28870136-Compound-52 decreases the phosphorylation of TSC22 domain family protein 4 (TSC22D4). [10]
Coumarin DM0N8ZM Investigative Coumarin affects the phosphorylation of TSC22 domain family protein 4 (TSC22D4). [10]
------------------------------------------------------------------------------------
5 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Tretinoin DM49DUI Approved Tretinoin increases the expression of TSC22 domain family protein 4 (TSC22D4). [5]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of TSC22 domain family protein 4 (TSC22D4). [6]
Estradiol DMUNTE3 Approved Estradiol decreases the expression of TSC22 domain family protein 4 (TSC22D4). [7]
Urethane DM7NSI0 Phase 4 Urethane increases the expression of TSC22 domain family protein 4 (TSC22D4). [9]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of TSC22 domain family protein 4 (TSC22D4). [11]
------------------------------------------------------------------------------------

References

1 The interplay between TGF--stimulated TSC22 domain family proteins regulates cell-cycle dynamics in medulloblastoma cells.J Cell Physiol. 2019 Aug;234(10):18349-18360. doi: 10.1002/jcp.28468. Epub 2019 Mar 25.
2 Control of diabetic hyperglycaemia and insulin resistance through TSC22D4.Nat Commun. 2016 Nov 9;7:13267. doi: 10.1038/ncomms13267.
3 Promotion of cellular senescence by THG-1/TSC22D4 knockout through activation of JUNB.Biochem Biophys Res Commun. 2020 Feb 19;522(4):897-902. doi: 10.1016/j.bbrc.2019.11.145. Epub 2019 Dec 3.
4 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
5 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
6 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
7 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
8 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
9 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
10 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
11 Environmental pollutant induced cellular injury is reflected in exosomes from placental explants. Placenta. 2020 Jan 1;89:42-49. doi: 10.1016/j.placenta.2019.10.008. Epub 2019 Oct 17.